Through professional development, FDA meets the regulatory challenges posed by new science and technology developments. In addition to supporting a broad regulatory science program—including professional development components—FDA fosters collaborative activities with scientific institutions, academia, and industry. Key professional development activities include:
- MCMi Lectures: MCMi supports lectures that cover a range of topics including guidance development, the policies, procedures, and framework for assessing applications for review, and other timely MCM topics. Lectures include:
- Foundations for Preclinical Review - monthly lecture series to engage subject matter experts from FDA Centers and offices on issues related to obtaining valid, reliable animal models for human disease. Goals include examining common study pitfalls and supporting consistent guidance development
- MCMi Lecture Series - to broaden the understanding of the policies, procedures, and US governmental framework for FDA reviewers who are assessing applications for medical products to counter CBRN threats
- MCMi Hot Topics - monthly scientific briefings on timely MCM-related topics of interest to FDA staff involved in the review of medical product applications. Subject matter experts from Federal agencies, academia, and industry are invited to speak on issues that are not product-specific
- Additional MCM Education Opportunities: FDA encourages staff to further their MCM education through specialized training, and by offering continuing education credits, where possible.
- MCMi Regulatory Science Symposium: MCMi has sponsored regulatory science symposia to exchange ideas on MCM development and explore the latest research. Webcast recordings are available.
- Advancing skills of FDA staff: FDA recruits and fosters top talent by providing innovative skill development programs to prepare staff to successfully address the regulatory challenges presented by new areas of science and medicine.
FDA hosts numerous public meetings and workshops each year. For MCM-related events, visit our News and Events page.
Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.